4Fox W. The current status of short course chemotherapy[J]. Bull int Union Tuberc, 1978,53:268 - 270.
5Rastog N, Goh KS, Bryskier A, et al. In vitro activities of levofloxacin used alone and in combination with first and second - line antituberculosis drugs against mycobacterium tuberculosis[J] . Antimicrob Agents Chemother, 1996,40:1610 - 1616.
6Klemens S P, Sharpe C A , Rogge M C, et al. Activity of levofloxacin in a murine model of tuberculosis[J] . Antimicrob Agents Chemother. 1994; 38:1476 - 1479.
7Ji B, Lounis N, Truffot - pernot C, et al. In Vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis[J]. Antimicrob Agents Chemother, 1995,39:1341 - 1344.
8American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children [J]. Am J Respir Crit Care Med., 1994,149:1359.
9Enarson DA, Chretien J. Epidemiology of respiratory infection diseases. Curr Opin Pulm Med, 1999 ;5 : 128.
10Helsal E, Arnadottir T, Cruz JR, et al. Low failure rate in standardised retreatment of tuberculosis in Nicaragua: patient category, drug resistance and survival of chronic patients. Int J Tuberc Lung Dis,2001 ;5(2) :129.
